Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...
In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism ...
TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products ...
AI can accelerate drug discovery, clinical development, and patient access, but regulatory hurdles remain. Anders Romare, ...